Mapping global variation in dengue transmission intensity
Lorenzo Cattarino, Isabel Rodríguez-Barraquer, Natsuko Imai, Derek A. T. Cummings, Neil M. Ferguson
Abstract
, even at intermediate efficacy (50% transmission reduction), might reduce global annual disease incidence by up to 90%. The Sanofi-Pasteur vaccine, targeting only seropositive recipients, might reduce global annual disease incidence by 20 to 30%, with the greatest impact in high-transmission settings. The transmission intensity map presented here, and made available for download, may help further assessment of the impact of dengue control interventions and prioritization of global public health efforts.
Topics & Concepts
Dengue feverTransmission (telecommunications)Environmental healthPsychological interventionGlobal healthDisease burdenIncidence (geometry)Tropical diseaseMedicineDengue virusGeographyDemographyDiseasePublic healthVirologyPopulationInternal medicinePhysicsNursingEngineeringElectrical engineeringSociologyPsychiatryOpticsMosquito-borne diseases and controlInsect symbiosis and bacterial influencesMalaria Research and Control